|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:FAF1-EIF5 (FusionGDB2 ID:28231) |
Fusion Gene Summary for FAF1-EIF5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: FAF1-EIF5 | Fusion gene ID: 28231 | Hgene | Tgene | Gene symbol | FAF1 | EIF5 | Gene ID | 11124 | 1983 |
Gene name | Fas associated factor 1 | eukaryotic translation initiation factor 5 | |
Synonyms | CGI-03|HFAF1s|UBXD12|UBXN3A|hFAF1 | EIF-5|EIF-5A | |
Cytomap | 1p32.3 | 14q32.32 | |
Type of gene | protein-coding | protein-coding | |
Description | FAS-associated factor 1Fas (TNFRSF6) associated factor 1TNFRSF6-associated factor 1UBX domain protein 3AUBX domain-containing protein 12UBX domain-containing protein 3A | eukaryotic translation initiation factor 5 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9UNN5 | O60841 | |
Ensembl transtripts involved in fusion gene | ENST00000371778, ENST00000396153, ENST00000545823, ENST00000472808, | ENST00000392715, ENST00000560200, ENST00000216554, ENST00000558506, | |
Fusion gene scores | * DoF score | 23 X 21 X 9=4347 | 11 X 10 X 6=660 |
# samples | 31 | 13 | |
** MAII score | log2(31/4347*10)=-3.80967997500385 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/660*10)=-2.34395440121736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FAF1 [Title/Abstract] AND EIF5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | FAF1(51048290)-EIF5(103805509), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | FAF1-EIF5 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. FAF1-EIF5 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. FAF1-EIF5 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FAF1 | GO:0010942 | positive regulation of cell death | 15596450 |
Tgene | EIF5 | GO:0006446 | regulation of translational initiation | 22156057 |
Fusion gene breakpoints across FAF1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across EIF5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | GBM | TCGA-14-1034-01A | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
Top |
Fusion Gene ORF analysis for FAF1-EIF5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000371778 | ENST00000392715 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5CDS-intron | ENST00000371778 | ENST00000560200 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5CDS-intron | ENST00000396153 | ENST00000392715 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5CDS-intron | ENST00000396153 | ENST00000560200 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5CDS-intron | ENST00000545823 | ENST00000392715 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5CDS-intron | ENST00000545823 | ENST00000560200 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5UTR-3CDS | ENST00000472808 | ENST00000216554 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5UTR-3CDS | ENST00000472808 | ENST00000558506 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5UTR-intron | ENST00000472808 | ENST00000392715 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
5UTR-intron | ENST00000472808 | ENST00000560200 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
Frame-shift | ENST00000371778 | ENST00000216554 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
Frame-shift | ENST00000371778 | ENST00000558506 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
In-frame | ENST00000396153 | ENST00000216554 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
In-frame | ENST00000396153 | ENST00000558506 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
In-frame | ENST00000545823 | ENST00000216554 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
In-frame | ENST00000545823 | ENST00000558506 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000396153 | FAF1 | chr1 | 51048290 | - | ENST00000216554 | EIF5 | chr14 | 103805509 | + | 6090 | 1565 | 140 | 2116 | 658 |
ENST00000396153 | FAF1 | chr1 | 51048290 | - | ENST00000558506 | EIF5 | chr14 | 103805509 | + | 4293 | 1565 | 140 | 2116 | 658 |
ENST00000545823 | FAF1 | chr1 | 51048290 | - | ENST00000216554 | EIF5 | chr14 | 103805509 | + | 5062 | 537 | 150 | 1088 | 312 |
ENST00000545823 | FAF1 | chr1 | 51048290 | - | ENST00000558506 | EIF5 | chr14 | 103805509 | + | 3265 | 537 | 150 | 1088 | 312 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000396153 | ENST00000216554 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + | 0.000125404 | 0.9998746 |
ENST00000396153 | ENST00000558506 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + | 0.000148174 | 0.9998518 |
ENST00000545823 | ENST00000216554 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + | 8.72E-05 | 0.99991274 |
ENST00000545823 | ENST00000558506 | FAF1 | chr1 | 51048290 | - | EIF5 | chr14 | 103805509 | + | 8.37E-05 | 0.9999163 |
Top |
Fusion Genomic Features for FAF1-EIF5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
FAF1 | chr1 | 51048289 | - | EIF5 | chr14 | 103805508 | + | 0.00188442 | 0.99811554 |
FAF1 | chr1 | 51048289 | - | EIF5 | chr14 | 103805508 | + | 0.00188442 | 0.99811554 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for FAF1-EIF5 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:51048290/chr14:103805509) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
FAF1 | EIF5 |
FUNCTION: Ubiquitin-binding protein (PubMed:19722279). Required for the progression of DNA replication forks by targeting DNA replication licensing factor CDT1 for degradation (PubMed:26842564). Potentiates but cannot initiate FAS-induced apoptosis (By similarity). {ECO:0000250|UniProtKB:P54731, ECO:0000269|PubMed:19722279, ECO:0000269|PubMed:26842564}. | FUNCTION: Plays a role in translation initiation. Translational GTPase that catalyzes the joining of the 40S and 60S subunits to form the 80S initiation complex with the initiator methionine-tRNA in the P-site base paired to the start codon. GTP binding and hydrolysis induces conformational changes in the enzyme that renders it active for productive interactions with the ribosome. The release of the enzyme after formation of the initiation complex is a prerequisite to form elongation-competent ribosomes. {ECO:0000250|UniProtKB:P39730}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FAF1 | chr1:51048290 | chr14:103805509 | ENST00000371778 | - | 13 | 20 | 1_57 | 371 | 651.0 | Domain | UBA |
Hgene | FAF1 | chr1:51048290 | chr14:103805509 | ENST00000396153 | - | 12 | 19 | 1_57 | 371 | 651.0 | Domain | UBA |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000216554 | 7 | 12 | 384_402 | 248 | 432.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000216554 | 7 | 12 | 423_429 | 248 | 432.0 | Compositional bias | Note=Asp-rich (acidic) | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000392715 | 6 | 11 | 384_402 | 248 | 432.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000392715 | 6 | 11 | 423_429 | 248 | 432.0 | Compositional bias | Note=Asp-rich (acidic) | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000558506 | 5 | 10 | 384_402 | 248 | 432.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000558506 | 5 | 10 | 423_429 | 248 | 432.0 | Compositional bias | Note=Asp-rich (acidic) |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FAF1 | chr1:51048290 | chr14:103805509 | ENST00000371778 | - | 13 | 20 | 569_646 | 371 | 651.0 | Domain | UBX |
Hgene | FAF1 | chr1:51048290 | chr14:103805509 | ENST00000396153 | - | 12 | 19 | 569_646 | 371 | 651.0 | Domain | UBX |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000216554 | 7 | 12 | 196_202 | 248 | 432.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000392715 | 6 | 11 | 196_202 | 248 | 432.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000558506 | 5 | 10 | 196_202 | 248 | 432.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000216554 | 7 | 12 | 233_392 | 248 | 432.0 | Domain | W2 | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000392715 | 6 | 11 | 233_392 | 248 | 432.0 | Domain | W2 | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000558506 | 5 | 10 | 233_392 | 248 | 432.0 | Domain | W2 | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000216554 | 7 | 12 | 27_34 | 248 | 432.0 | Nucleotide binding | GTP | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000392715 | 6 | 11 | 27_34 | 248 | 432.0 | Nucleotide binding | GTP | |
Tgene | EIF5 | chr1:51048290 | chr14:103805509 | ENST00000558506 | 5 | 10 | 27_34 | 248 | 432.0 | Nucleotide binding | GTP |
Top |
Fusion Gene Sequence for FAF1-EIF5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>28231_28231_1_FAF1-EIF5_FAF1_chr1_51048290_ENST00000396153_EIF5_chr14_103805509_ENST00000216554_length(transcript)=6090nt_BP=1565nt AGGGGCGGAGGCGGCGGCCAGGGAGGAAGCGGAGGAGGCGGAGGCGGCCGCGGCGTTCGCCCGCCCGCTCGCTCGCTCGGTTTCCCCGCC CCCGCCGGGCTTAACGCCGCTGAAGGTATCCGGGTGCGCGCTGTCGCAACCTGCCCTCATCCTGGCCCGCGACTGTAAGACCGGACCCAC ATCCAGACCAATCTTCCTGTCCGGGCTGCTGCGACGCGGGCTCCGCAGGTTGCAGGCGGGCGGCCGGGGCGCCTGAAGGTTACCGAGTGC ATGAGCGCCTAGCGCTTCCCGCGCTGCCCCGCCCGCTGGCCCGCCGACCCGCCCGCCGGCTCGCCCGCCAGCCCCTCGGCGCCCGGCGGC GGCGGCGGCGGTGGCGGCGACGGTCGCAGGAGGTGCCGTCTGCCTCCCAGGTGCGCGCTTCGCTCCCGGAGCCGCGGAACTCGGCGGCCG CCATGGCGTCCAACATGGACCGGGAGATGATCCTGGCGGATTTTCAGGCATGTACTGGCATTGAAAACATTGACGAAGCTATTACATTGC TTGAACAAAATAATTGGGACTTAGTGGCAGCTATCAATGGTGTAATACCACAGGAAAATGGCATTCTACAAAGTGAATATGGAGGTGAGA CCATACCAGGACCTGCATTTAATCCAGCAAGTCATCCAGCTTCAGCTCCTACTTCCTCTTCTTCTTCAGCGTTTCGACCTGTAATGCCAT CCAGGCAGATTGTAGAAAGGCAACCTCGGATGCTGGACTTCAGGGTTGAATACAGAGACAGAAATGTTGATGTGGTACTTGAAGACACCT GTACTGTTGGAGAGATTAAACAGATTCTAGAAAATGAACTTCAGATACCTGTGTCCAAAATGCTGTTAAAAGGCTGGAAGACGGGAGATG TGGAAGACAGTACGGTCCTAAAATCTCTACACTTGCCAAAAAACAACAGTCTTTATGTCCTTACACCAGATTTGCCACCACCTTCATCAT CTAGTCATGCTGGTGCCCTGCAGGAGTCATTAAATCAAAACTTCATGCTGATCATCACCCACCGAGAAGTCCAGCGGGAGTACAACCTGA ACTTCTCAGGAAGCAGTACTATTCAAGAGGTAAAGAGAAATGTGTATGACCTTACAAGTATCCCCGTTCGCCACCAATTATGGGAGGGCT GGCCAACTTCTGCTACAGACGACTCAATGTGTCTTGCTGAATCAGGGCTCTCTTATCCCTGCCATCGACTTACAGTGGGAAGAAGATCTT CACCTGCACAGACCCGGGAACAGTCGGAAGAACAAATCACCGATGTTCATATGGTTAGTGATAGCGATGGAGATGACTTTGAAGATGCTA CAGAATTTGGGGTGGATGATGGAGAAGTATTTGGCATGGCGTCATCTGCCTTGAGAAAATCTCCAATGATGCCAGAAAACGCAGAAAATG AAGGAGATGCCTTATTACAATTTACAGCAGAGTTTTCTTCAAGATATGGTGATTGCCATCCTGTATTTTTTATTGGCTCATTAGAAGCTG CTTTTCAAGAGGCCTTCTATGTGAAAGCCCGAGATAAAAAGAAAGAAGAGGGTGTTATTGATTCATCTGACAAAGAAATCGTTGCTGAAG CAGAAAGACTGGATGTAAAAGCCATGGGCCCTCTTGTTCTAACTGAAGTTCTTTTTAATGAGAAGATTAGAGAACAGATTAAGAAATACA GGCGCCATTTCCTACGATTTTGTCACAACAACAAAAAAGCCCAACGGTACCTTCTTCATGGTTTGGAGTGTGTGGTAGCAATGCATCAAG CTCAGCTTATCTCCAAGATTCCACATATCTTGAAGGAGATGTACGATGCAGACCTTTTAGAAGAAGAGGTCATCATCAGCTGGTCGGAAA AGGCCTCTAAGAAATATGTCTCCAAAGAACTTGCCAAAGAGATTCGTGTCAAAGCAGAACCATTTATAAAATGGTTGAAGGAGGCAGAGG AAGAATCTTCTGGTGGCGAAGAAGAAGATGAAGATGAGAACATTGAGGTGGTGTATTCGAAGGCTGCCAGTGTACCGAAAGTTGAGACTG TAAAGTCAGACAACAAGGATGACGACATCGATATTGATGCCATTTAAAGGGATGGATGCAACCTAGCTTAACAGTATAATGCTGCAAATT TTCCTCCATTATCAGCCAGAAGTGCAACATGTATGTGCAAAAGCTAAAATGGCTTAACATCATGCTACACTTTACACTAAAAATCTATTA CTGTGAGTGGTCTGTTATTAAGCCCAATGAGACATCTAGGGAGTCCATACACATCAGTGAGCAGATGTAGTTTGCTTATTTATAGCATGT TTCTTTTTGAAAAACTAGTGGTGGACACATTTGGATCACATTTATACAGTTATAAAAATAAAGGTTTGATTTTGGTCGTTCTTCAGATGT TTGGCTCTGAATGACTTAAGCTGAAGTAACTGGCTCCTTACTTTAAATGTTCTGCCATCATTTCACCTGATGAGCATTCTTGGAGCCTGC CAGATATTGTTAGGTCCTGGGGCTGCAAAGAGGTCCTCAACAGGATGTAAAGCAAACTTAATTGTAATTAATTTATTCAGCCCATTAAGA AAGTACTAAAGTTTTATCTCTGTAGTTCCTCAAATTGGCATCTGGTAATGTACATTGTGAGGTAGACTGATAATGAAATGACAGTGTAAC ATCTTAACCAAGAAGTAAATATGACCTCAGTGTCCTATAAATAATGTAAGAGCAGGATTTGAAACTTGGAGAGCTGTTTTCTCATTTCAT GTACACTTGCCCCAAATTGTCTTTGAAGTCGTGTGCATTGCACGTTGGATGAGCCAGGGAAATTATTACATTAACAAGCATTTTGTGTGT ACGTAGTAGTTACTTTGTACTGAGAGAACTTGCTTTGGGGTGCAATTAATAAACTGATTTTATTTGGGAGAAACAAGGAAGGGTGCACTT AACTAGCAACCTAAGCATGATTTTTCAGCTTTTGCCCTTAGGGTTTAAATTACAATTCCAAAATGTTAGACATACTGTATTTTTTCGTTC AGTGTGGCTTTAATTTTCCCCTCTTGCAGTTTGTTCTGTAATGCCTTTTACATTTGGACACATAGTTTATGCTTTTTAGATTTTGGTTGC TTTCTTGCCAAAATAAGTGTTAACTGTGTTTCAAACTTGATTTTCTTTCCTTTTTCTTTTTTTTTTCTTCCAGAATGTCTTATTTAAAAA GAAAGCTAAAAGCATACTTCTAAGTCAGAGCCTCTATTTTGGTGTAAGACTTGGGATATTTTTTACTTCACATTGAATATAGCCAGGCAC CCAAGAAGTCTGATGGCCACCTGAGTGCAGGTGACAAGGACCTGACAGAGCCCATGCAGGGCTTTAGATTTGGACACACAAGAGTTGATA ACTTCCTCATGAACTCCTTGCCTGATCTAAACTCATATTATGGGTTCTGACTGTTTGAGTAATCATCTTCAAGGTTAAACCTCTTGGCAG TTACCCTTTTCACAAAGTGCACAGTGGGAATCGAGAATCGATAGGGTTAATTTTGGAGCAGTGGCTTATACCATTCACCTCTGTTTTTTT GTGATTATTTCACAGATAATGAGACCTTAATAACAAATAGGCGTAAAAAAATTTTCACATTGAAATGATAGAAACATTTGATGTAATAAA ACTTGGTTGGCTTGATATTTTAAGGAATTGAAACCTAGCAATCTTATTGGAGAGACAAGAATTGGTCTCCAGCTGCCTTTGATCAAGATT CGGGTGCAAGTGGAGCAGGAGCCATATACCTGGAGGGAATGTGCTTTGTCACACCAAAGAGGATTTTTTTTTCTTCAAACTTGTATGTTG CCTAGGTTTCAAATTCTTTGCCGCAAGGCTGATCTGCTTTCATTAACTGGAATTCTGTAGGAGATACTGGTGACCTAAGCTAAGTTGCAC TCAGCATACTCAGTGTCAAGCTAATGAGGTTCTATTATAAAGGTTCTACTTTTAATCTGAGGGAAAACATGTTCAGGGCTTCTAGAACAC TAAAAAATTTGGCTTAAACCAGTGTTCAGTCTGGTGCCAAACTTCGAATGGAATACAAATTCACATAATCTGAACTTTGTTCACAGGTTA TCCTAATAGAGTAATTCTTCACTTTGCTCTATTGAACTGTCTTAAGGATTTGTTTAAACAGCTAAGTTACTTGATTAAAATAATGATAAA ATTGTATTTTGTCTTTGCTTTAATATTAAAGTTAACAAGTTTTCATTTTATAATGAGATCAAAGCATTGGAATCTGCCCTGTTTTGTAGC CGTTGCTTTGGATTTGTGTTGGATGTATCCTGCAGTTACACTTGCCAGCCCCACTCACAAAAGTTGTTCATTTCATTGGGTCACTGGCTT TATTTGCTAGTCTTGTCTGTGAACTGAGCATCTGCCTCAGTTTTATTACTTGAAATCTTGGCAGGTGCTTAATAGGGAACATACATACAG CTATGTAACTGTGAATAATTGTATATATCTCTAGTTAAGAATGAGGGAATGGGGAGGTTTGCTTTCTAAACAAGTGCATTCTGAAATTGA CTTAAAAATTTTTAGTGTGGGTCCTAAAGTTTAGAGATGGGCAAGGAGGTCTCTAATCCACCGCTTCCCGCTTGAGAAGGGAGGGGTATC AAAATTGAGCCCCAAGCTGTTTGTTCCAGTGTACCAAGCACTGACTTTATGCCTTTGGCCTGGAGATGGCAGAAGTGAAAGCTGGCCATC TGCAAAAAGCAGATAAGTGAGTTTGAACCTTTTGCATTTTGTTAGCTCAGTCAGTCCTCATCGTGGTCCTGAGGCATAGGTACTGTTGTA CCAAGGTCACTTATCTAACAAAATAACCCTTCATGTATTTTAAATTTATTTGACAAGTCTGCAGACAATCCTTATCTAACCAGCTATTTT CTTAATTGCTACAGCTTGACCTACCAGTATTCCGGAGTAACCAGCAAATGCAAAGTTGACCTTGTTCCTGCATCATCTTTTTGATGGTTC AAATTTCAGCCTCCCTGACTACTACAAAGCCAGAGCAGTCTTAGTACCAGAAACAGTGTTGCACTTTCGTTGCATGTGCTGTGTGACCCC AAGGGGACAGGGAGTCACTTTGGTCATCTCTGTCCCCAGTACAGATCTTGATTCATAGTGACATTCCATAAGTGGGGTGACAGCAAATGA CTTGCAGGTAGTCTCATTGTAGGTTTGTGCACCAGAGTGACCCTGTGAGCCTTTGTTAATAGGTTGGGAGCTCAGGGTGTTTATGTCCAC CTGTCTGGTCTAGCCAAACAGTTTTTTTCTGGGAATCAAATTTCTGTGGTTTTTATGGCCAGAAATTTTAAGGACTTGTGTGTGCTGGGA TATGAGAATAGAAGCTACAGAGTTCTTTTCTTGGGACCTAGACTGGGAGGTGCAATGTCAGGACCTCCAGGTGAATGGTAGGATCTGAGT TGACCCTGCAGTTCGGTTATGCAGTCAATTATTTCTTTTTAAGAGGAGGAGGATTCACTTGGGTGTTGGGATCAAATTTGGATTCTGTCC CAGGCCTTACTGTAAAACTAGGGGATTGCCTTTCCATATCTGCTGGGGGTGGAGACCCTTATGTGCAGCACTCAATCCCACTGGAAGCCT AATGCTGCAGTCAGAAGCAATGCCTGGCTGGGGCAGTAGGGGAAATTCCACCCAATTTTGCTATGAGCCTAAAACCTCTTTAAAAACGGT CAGTTAACTAAAAAATAAAAATCAAGTCTTTAGGAGAGTAGAAAACACAATTAACTAAAAAGCAGGGACATCTGAAAGAGACGTATTAAG TTAACATTTTTAAAAATCCAAATGAAAGTAAATGGAATAAATGTATCAGGTAAAGGACAAGTTGTAAGCTTGGATTTTTAGGTCTAGCAA TACACTGTTTACAAGAGCATCACCTAAAATGTGACAAAAGATGTTGAAAGGATGAAAAAAGGTATAGTAGACATACACTAACCAAAAATG >28231_28231_1_FAF1-EIF5_FAF1_chr1_51048290_ENST00000396153_EIF5_chr14_103805509_ENST00000216554_length(amino acids)=658AA_BP=475 MPSSWPATVRPDPHPDQSSCPGCCDAGSAGCRRAAGAPEGYRVHERLALPALPRPLARRPARRLARQPLGARRRRRRWRRRSQEVPSASQ VRASLPEPRNSAAAMASNMDREMILADFQACTGIENIDEAITLLEQNNWDLVAAINGVIPQENGILQSEYGGETIPGPAFNPASHPASAP TSSSSSAFRPVMPSRQIVERQPRMLDFRVEYRDRNVDVVLEDTCTVGEIKQILENELQIPVSKMLLKGWKTGDVEDSTVLKSLHLPKNNS LYVLTPDLPPPSSSSHAGALQESLNQNFMLIITHREVQREYNLNFSGSSTIQEVKRNVYDLTSIPVRHQLWEGWPTSATDDSMCLAESGL SYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGDALLQFTAEFSSRYG DCHPVFFIGSLEAAFQEAFYVKARDKKKEEGVIDSSDKEIVAEAERLDVKAMGPLVLTEVLFNEKIREQIKKYRRHFLRFCHNNKKAQRY LLHGLECVVAMHQAQLISKIPHILKEMYDADLLEEEVIISWSEKASKKYVSKELAKEIRVKAEPFIKWLKEAEEESSGGEEEDEDENIEV -------------------------------------------------------------- >28231_28231_2_FAF1-EIF5_FAF1_chr1_51048290_ENST00000396153_EIF5_chr14_103805509_ENST00000558506_length(transcript)=4293nt_BP=1565nt AGGGGCGGAGGCGGCGGCCAGGGAGGAAGCGGAGGAGGCGGAGGCGGCCGCGGCGTTCGCCCGCCCGCTCGCTCGCTCGGTTTCCCCGCC CCCGCCGGGCTTAACGCCGCTGAAGGTATCCGGGTGCGCGCTGTCGCAACCTGCCCTCATCCTGGCCCGCGACTGTAAGACCGGACCCAC ATCCAGACCAATCTTCCTGTCCGGGCTGCTGCGACGCGGGCTCCGCAGGTTGCAGGCGGGCGGCCGGGGCGCCTGAAGGTTACCGAGTGC ATGAGCGCCTAGCGCTTCCCGCGCTGCCCCGCCCGCTGGCCCGCCGACCCGCCCGCCGGCTCGCCCGCCAGCCCCTCGGCGCCCGGCGGC GGCGGCGGCGGTGGCGGCGACGGTCGCAGGAGGTGCCGTCTGCCTCCCAGGTGCGCGCTTCGCTCCCGGAGCCGCGGAACTCGGCGGCCG CCATGGCGTCCAACATGGACCGGGAGATGATCCTGGCGGATTTTCAGGCATGTACTGGCATTGAAAACATTGACGAAGCTATTACATTGC TTGAACAAAATAATTGGGACTTAGTGGCAGCTATCAATGGTGTAATACCACAGGAAAATGGCATTCTACAAAGTGAATATGGAGGTGAGA CCATACCAGGACCTGCATTTAATCCAGCAAGTCATCCAGCTTCAGCTCCTACTTCCTCTTCTTCTTCAGCGTTTCGACCTGTAATGCCAT CCAGGCAGATTGTAGAAAGGCAACCTCGGATGCTGGACTTCAGGGTTGAATACAGAGACAGAAATGTTGATGTGGTACTTGAAGACACCT GTACTGTTGGAGAGATTAAACAGATTCTAGAAAATGAACTTCAGATACCTGTGTCCAAAATGCTGTTAAAAGGCTGGAAGACGGGAGATG TGGAAGACAGTACGGTCCTAAAATCTCTACACTTGCCAAAAAACAACAGTCTTTATGTCCTTACACCAGATTTGCCACCACCTTCATCAT CTAGTCATGCTGGTGCCCTGCAGGAGTCATTAAATCAAAACTTCATGCTGATCATCACCCACCGAGAAGTCCAGCGGGAGTACAACCTGA ACTTCTCAGGAAGCAGTACTATTCAAGAGGTAAAGAGAAATGTGTATGACCTTACAAGTATCCCCGTTCGCCACCAATTATGGGAGGGCT GGCCAACTTCTGCTACAGACGACTCAATGTGTCTTGCTGAATCAGGGCTCTCTTATCCCTGCCATCGACTTACAGTGGGAAGAAGATCTT CACCTGCACAGACCCGGGAACAGTCGGAAGAACAAATCACCGATGTTCATATGGTTAGTGATAGCGATGGAGATGACTTTGAAGATGCTA CAGAATTTGGGGTGGATGATGGAGAAGTATTTGGCATGGCGTCATCTGCCTTGAGAAAATCTCCAATGATGCCAGAAAACGCAGAAAATG AAGGAGATGCCTTATTACAATTTACAGCAGAGTTTTCTTCAAGATATGGTGATTGCCATCCTGTATTTTTTATTGGCTCATTAGAAGCTG CTTTTCAAGAGGCCTTCTATGTGAAAGCCCGAGATAAAAAGAAAGAAGAGGGTGTTATTGATTCATCTGACAAAGAAATCGTTGCTGAAG CAGAAAGACTGGATGTAAAAGCCATGGGCCCTCTTGTTCTAACTGAAGTTCTTTTTAATGAGAAGATTAGAGAACAGATTAAGAAATACA GGCGCCATTTCCTACGATTTTGTCACAACAACAAAAAAGCCCAACGGTACCTTCTTCATGGTTTGGAGTGTGTGGTAGCAATGCATCAAG CTCAGCTTATCTCCAAGATTCCACATATCTTGAAGGAGATGTACGATGCAGACCTTTTAGAAGAAGAGGTCATCATCAGCTGGTCGGAAA AGGCCTCTAAGAAATATGTCTCCAAAGAACTTGCCAAAGAGATTCGTGTCAAAGCAGAACCATTTATAAAATGGTTGAAGGAGGCAGAGG AAGAATCTTCTGGTGGCGAAGAAGAAGATGAAGATGAGAACATTGAGGTGGTGTATTCGAAGGCTGCCAGTGTACCGAAAGTTGAGACTG TAAAGTCAGACAACAAGGATGACGACATCGATATTGATGCCATTTAAAGGGATGGATGCAACCTAGCTTAACAGTATAATGCTGCAAATT TTCCTCCATTATCAGCCAGAAGTGCAACATGTATGTGCAAAAGCTAAAATGGCTTAACATCATGCTACACTTTACACTAAAAATCTATTA CTGTGAGTGGTCTGTTATTAAGCCCAATGAGACATCTAGGGAGTCCATACACATCAGTGAGCAGATGTAGTTTGCTTATTTATAGCATGT TTCTTTTTGAAAAACTAGTGGTGGACACATTTGGATCACATTTATACAGTTATAAAAATAAAGGTTTGATTTTGGTCGTTCTTCAGATGT TTGGCTCTGAATGACTTAAGCTGAAGTAACTGGCTCCTTACTTTAAATGTTCTGCCATCATTTCACCTGATGAGCATTCTTGGAGCCTGC CAGATATTGTTAGGTCCTGGGGCTGCAAAGAGGTCCTCAACAGGATGTAAAGCAAACTTAATTGTAATTAATTTATTCAGCCCATTAAGA AAGTACTAAAGTTTTATCTCTGTAGTTCCTCAAATTGGCATCTGGTAATGTACATTGTGAGGTAGACTGATAATGAAATGACAGTGTAAC ATCTTAACCAAGAAGTAAATATGACCTCAGTGTCCTATAAATAATGTAAGAGCAGGATTTGAAACTTGGAGAGCTGTTTTCTCATTTCAT GTACACTTGCCCCAAATTGTCTTTGAAGTCGTGTGCATTGCACGTTGGATGAGCCAGGGAAATTATTACATTAACAAGCATTTTGTGTGT ACGTAGTAGTTACTTTGTACTGAGAGAACTTGCTTTGGGGTGCAATTAATAAACTGATTTTATTTGGGAGAAACAAGGAAGGGTGCACTT AACTAGCAACCTAAGCATGATTTTTCAGCTTTTGCCCTTAGGGTTTAAATTACAATTCCAAAATGTTAGACATACTGTATTTTTTCGTTC AGTGTGGCTTTAATTTTCCCCTCTTGCAGTTTGTTCTGTAATGCCTTTTACATTTGGACACATAGTTTATGCTTTTTAGATTTTGGTTGC TTTCTTGCCAAAATAAGTGTTAACTGTGTTTCAAACTTGATTTTCTTTCCTTTTTCTTTTTTTTTTCTTCCAGAATGTCTTATTTAAAAA GAAAGCTAAAAGCATACTTCTAAGTCAGAGCCTCTATTTTGGTGTAAGACTTGGGATATTTTTTACTTCACATTGAATATAGCCAGGCAC CCAAGAAGTCTGATGGCCACCTGAGTGCAGGTGACAAGGACCTGACAGAGCCCATGCAGGGCTTTAGATTTGGACACACAAGAGTTGATA ACTTCCTCATGAACTCCTTGCCTGATCTAAACTCATATTATGGGTTCTGACTGTTTGAGTAATCATCTTCAAGGTTAAACCTCTTGGCAG TTACCCTTTTCACAAAGTGCACAGTGGGAATCGAGAATCGATAGGGTTAATTTTGGAGCAGTGGCTTATACCATTCACCTCTGTTTTTTT GTGATTATTTCACAGATAATGAGACCTTAATAACAAATAGGCGTAAAAAAATTTTCACATTGAAATGATAGAAACATTTGATGTAATAAA ACTTGGTTGGCTTGATATTTTAAGGAATTGAAACCTAGCAATCTTATTGGAGAGACAAGAATTGGTCTCCAGCTGCCTTTGATCAAGATT CGGGTGCAAGTGGAGCAGGAGCCATATACCTGGAGGGAATGTGCTTTGTCACACCAAAGAGGATTTTTTTTTCTTCAAACTTGTATGTTG CCTAGGTTTCAAATTCTTTGCCGCAAGGCTGATCTGCTTTCATTAACTGGAATTCTGTAGGAGATACTGGTGACCTAAGCTAAGTTGCAC TCAGCATACTCAGTGTCAAGCTAATGAGGTTCTATTATAAAGGTTCTACTTTTAATCTGAGGGAAAACATGTTCAGGGCTTCTAGAACAC TAAAAAATTTGGCTTAAACCAGTGTTCAGTCTGGTGCCAAACTTCGAATGGAATACAAATTCACATAATCTGAACTTTGTTCACAGGTTA TCCTAATAGAGTAATTCTTCACTTTGCTCTATTGAACTGTCTTAAGGATTTGTTTAAACAGCTAAGTTACTTGATTAAAATAATGATAAA >28231_28231_2_FAF1-EIF5_FAF1_chr1_51048290_ENST00000396153_EIF5_chr14_103805509_ENST00000558506_length(amino acids)=658AA_BP=475 MPSSWPATVRPDPHPDQSSCPGCCDAGSAGCRRAAGAPEGYRVHERLALPALPRPLARRPARRLARQPLGARRRRRRWRRRSQEVPSASQ VRASLPEPRNSAAAMASNMDREMILADFQACTGIENIDEAITLLEQNNWDLVAAINGVIPQENGILQSEYGGETIPGPAFNPASHPASAP TSSSSSAFRPVMPSRQIVERQPRMLDFRVEYRDRNVDVVLEDTCTVGEIKQILENELQIPVSKMLLKGWKTGDVEDSTVLKSLHLPKNNS LYVLTPDLPPPSSSSHAGALQESLNQNFMLIITHREVQREYNLNFSGSSTIQEVKRNVYDLTSIPVRHQLWEGWPTSATDDSMCLAESGL SYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGDALLQFTAEFSSRYG DCHPVFFIGSLEAAFQEAFYVKARDKKKEEGVIDSSDKEIVAEAERLDVKAMGPLVLTEVLFNEKIREQIKKYRRHFLRFCHNNKKAQRY LLHGLECVVAMHQAQLISKIPHILKEMYDADLLEEEVIISWSEKASKKYVSKELAKEIRVKAEPFIKWLKEAEEESSGGEEEDEDENIEV -------------------------------------------------------------- >28231_28231_3_FAF1-EIF5_FAF1_chr1_51048290_ENST00000545823_EIF5_chr14_103805509_ENST00000216554_length(transcript)=5062nt_BP=537nt ATACAAAGCAGGCTTGAGATGTATCCTTGCATATTTGAAGGTTCTGTGGTTATGATGAGCTGAAATGACCACTGATTAATACAGTAGCTC TCTAAAATAATGAGGTTTCTCCACTAACGGAACCTCTTTATTTATCAAACTTATAATAAAATGAGGAATCTGCTTGAGATGTGTCTTGCT GAATCAGGGCTCTCTTATCCCTGCCATCGACTTACAGTGGGAAGAAGATCTTCACCTGCACAGACCCGGGAACAGTCGGAAGAACAAATC ACCGATGTTCATATGGTTAGTGATAGCGATGGAGATGACTTTGAAGATGCTACAGAATTTGGGGTGGATGATGGAGAAGTATTTGGCATG GCGTCATCTGCCTTGAGAAAATCTCCAATGATGCCAGAAAACGCAGAAAATGAAGGAGATGCCTTATTACAATTTACAGCAGAGTTTTCT TCAAGATATGGTGATTGCCATCCTGTATTTTTTATTGGCTCATTAGAAGCTGCTTTTCAAGAGGCCTTCTATGTGAAAGCCCGAGATAAA AAGAAAGAAGAGGGTGTTATTGATTCATCTGACAAAGAAATCGTTGCTGAAGCAGAAAGACTGGATGTAAAAGCCATGGGCCCTCTTGTT CTAACTGAAGTTCTTTTTAATGAGAAGATTAGAGAACAGATTAAGAAATACAGGCGCCATTTCCTACGATTTTGTCACAACAACAAAAAA GCCCAACGGTACCTTCTTCATGGTTTGGAGTGTGTGGTAGCAATGCATCAAGCTCAGCTTATCTCCAAGATTCCACATATCTTGAAGGAG ATGTACGATGCAGACCTTTTAGAAGAAGAGGTCATCATCAGCTGGTCGGAAAAGGCCTCTAAGAAATATGTCTCCAAAGAACTTGCCAAA GAGATTCGTGTCAAAGCAGAACCATTTATAAAATGGTTGAAGGAGGCAGAGGAAGAATCTTCTGGTGGCGAAGAAGAAGATGAAGATGAG AACATTGAGGTGGTGTATTCGAAGGCTGCCAGTGTACCGAAAGTTGAGACTGTAAAGTCAGACAACAAGGATGACGACATCGATATTGAT GCCATTTAAAGGGATGGATGCAACCTAGCTTAACAGTATAATGCTGCAAATTTTCCTCCATTATCAGCCAGAAGTGCAACATGTATGTGC AAAAGCTAAAATGGCTTAACATCATGCTACACTTTACACTAAAAATCTATTACTGTGAGTGGTCTGTTATTAAGCCCAATGAGACATCTA GGGAGTCCATACACATCAGTGAGCAGATGTAGTTTGCTTATTTATAGCATGTTTCTTTTTGAAAAACTAGTGGTGGACACATTTGGATCA CATTTATACAGTTATAAAAATAAAGGTTTGATTTTGGTCGTTCTTCAGATGTTTGGCTCTGAATGACTTAAGCTGAAGTAACTGGCTCCT TACTTTAAATGTTCTGCCATCATTTCACCTGATGAGCATTCTTGGAGCCTGCCAGATATTGTTAGGTCCTGGGGCTGCAAAGAGGTCCTC AACAGGATGTAAAGCAAACTTAATTGTAATTAATTTATTCAGCCCATTAAGAAAGTACTAAAGTTTTATCTCTGTAGTTCCTCAAATTGG CATCTGGTAATGTACATTGTGAGGTAGACTGATAATGAAATGACAGTGTAACATCTTAACCAAGAAGTAAATATGACCTCAGTGTCCTAT AAATAATGTAAGAGCAGGATTTGAAACTTGGAGAGCTGTTTTCTCATTTCATGTACACTTGCCCCAAATTGTCTTTGAAGTCGTGTGCAT TGCACGTTGGATGAGCCAGGGAAATTATTACATTAACAAGCATTTTGTGTGTACGTAGTAGTTACTTTGTACTGAGAGAACTTGCTTTGG GGTGCAATTAATAAACTGATTTTATTTGGGAGAAACAAGGAAGGGTGCACTTAACTAGCAACCTAAGCATGATTTTTCAGCTTTTGCCCT TAGGGTTTAAATTACAATTCCAAAATGTTAGACATACTGTATTTTTTCGTTCAGTGTGGCTTTAATTTTCCCCTCTTGCAGTTTGTTCTG TAATGCCTTTTACATTTGGACACATAGTTTATGCTTTTTAGATTTTGGTTGCTTTCTTGCCAAAATAAGTGTTAACTGTGTTTCAAACTT GATTTTCTTTCCTTTTTCTTTTTTTTTTCTTCCAGAATGTCTTATTTAAAAAGAAAGCTAAAAGCATACTTCTAAGTCAGAGCCTCTATT TTGGTGTAAGACTTGGGATATTTTTTACTTCACATTGAATATAGCCAGGCACCCAAGAAGTCTGATGGCCACCTGAGTGCAGGTGACAAG GACCTGACAGAGCCCATGCAGGGCTTTAGATTTGGACACACAAGAGTTGATAACTTCCTCATGAACTCCTTGCCTGATCTAAACTCATAT TATGGGTTCTGACTGTTTGAGTAATCATCTTCAAGGTTAAACCTCTTGGCAGTTACCCTTTTCACAAAGTGCACAGTGGGAATCGAGAAT CGATAGGGTTAATTTTGGAGCAGTGGCTTATACCATTCACCTCTGTTTTTTTGTGATTATTTCACAGATAATGAGACCTTAATAACAAAT AGGCGTAAAAAAATTTTCACATTGAAATGATAGAAACATTTGATGTAATAAAACTTGGTTGGCTTGATATTTTAAGGAATTGAAACCTAG CAATCTTATTGGAGAGACAAGAATTGGTCTCCAGCTGCCTTTGATCAAGATTCGGGTGCAAGTGGAGCAGGAGCCATATACCTGGAGGGA ATGTGCTTTGTCACACCAAAGAGGATTTTTTTTTCTTCAAACTTGTATGTTGCCTAGGTTTCAAATTCTTTGCCGCAAGGCTGATCTGCT TTCATTAACTGGAATTCTGTAGGAGATACTGGTGACCTAAGCTAAGTTGCACTCAGCATACTCAGTGTCAAGCTAATGAGGTTCTATTAT AAAGGTTCTACTTTTAATCTGAGGGAAAACATGTTCAGGGCTTCTAGAACACTAAAAAATTTGGCTTAAACCAGTGTTCAGTCTGGTGCC AAACTTCGAATGGAATACAAATTCACATAATCTGAACTTTGTTCACAGGTTATCCTAATAGAGTAATTCTTCACTTTGCTCTATTGAACT GTCTTAAGGATTTGTTTAAACAGCTAAGTTACTTGATTAAAATAATGATAAAATTGTATTTTGTCTTTGCTTTAATATTAAAGTTAACAA GTTTTCATTTTATAATGAGATCAAAGCATTGGAATCTGCCCTGTTTTGTAGCCGTTGCTTTGGATTTGTGTTGGATGTATCCTGCAGTTA CACTTGCCAGCCCCACTCACAAAAGTTGTTCATTTCATTGGGTCACTGGCTTTATTTGCTAGTCTTGTCTGTGAACTGAGCATCTGCCTC AGTTTTATTACTTGAAATCTTGGCAGGTGCTTAATAGGGAACATACATACAGCTATGTAACTGTGAATAATTGTATATATCTCTAGTTAA GAATGAGGGAATGGGGAGGTTTGCTTTCTAAACAAGTGCATTCTGAAATTGACTTAAAAATTTTTAGTGTGGGTCCTAAAGTTTAGAGAT GGGCAAGGAGGTCTCTAATCCACCGCTTCCCGCTTGAGAAGGGAGGGGTATCAAAATTGAGCCCCAAGCTGTTTGTTCCAGTGTACCAAG CACTGACTTTATGCCTTTGGCCTGGAGATGGCAGAAGTGAAAGCTGGCCATCTGCAAAAAGCAGATAAGTGAGTTTGAACCTTTTGCATT TTGTTAGCTCAGTCAGTCCTCATCGTGGTCCTGAGGCATAGGTACTGTTGTACCAAGGTCACTTATCTAACAAAATAACCCTTCATGTAT TTTAAATTTATTTGACAAGTCTGCAGACAATCCTTATCTAACCAGCTATTTTCTTAATTGCTACAGCTTGACCTACCAGTATTCCGGAGT AACCAGCAAATGCAAAGTTGACCTTGTTCCTGCATCATCTTTTTGATGGTTCAAATTTCAGCCTCCCTGACTACTACAAAGCCAGAGCAG TCTTAGTACCAGAAACAGTGTTGCACTTTCGTTGCATGTGCTGTGTGACCCCAAGGGGACAGGGAGTCACTTTGGTCATCTCTGTCCCCA GTACAGATCTTGATTCATAGTGACATTCCATAAGTGGGGTGACAGCAAATGACTTGCAGGTAGTCTCATTGTAGGTTTGTGCACCAGAGT GACCCTGTGAGCCTTTGTTAATAGGTTGGGAGCTCAGGGTGTTTATGTCCACCTGTCTGGTCTAGCCAAACAGTTTTTTTCTGGGAATCA AATTTCTGTGGTTTTTATGGCCAGAAATTTTAAGGACTTGTGTGTGCTGGGATATGAGAATAGAAGCTACAGAGTTCTTTTCTTGGGACC TAGACTGGGAGGTGCAATGTCAGGACCTCCAGGTGAATGGTAGGATCTGAGTTGACCCTGCAGTTCGGTTATGCAGTCAATTATTTCTTT TTAAGAGGAGGAGGATTCACTTGGGTGTTGGGATCAAATTTGGATTCTGTCCCAGGCCTTACTGTAAAACTAGGGGATTGCCTTTCCATA TCTGCTGGGGGTGGAGACCCTTATGTGCAGCACTCAATCCCACTGGAAGCCTAATGCTGCAGTCAGAAGCAATGCCTGGCTGGGGCAGTA GGGGAAATTCCACCCAATTTTGCTATGAGCCTAAAACCTCTTTAAAAACGGTCAGTTAACTAAAAAATAAAAATCAAGTCTTTAGGAGAG TAGAAAACACAATTAACTAAAAAGCAGGGACATCTGAAAGAGACGTATTAAGTTAACATTTTTAAAAATCCAAATGAAAGTAAATGGAAT AAATGTATCAGGTAAAGGACAAGTTGTAAGCTTGGATTTTTAGGTCTAGCAATACACTGTTTACAAGAGCATCACCTAAAATGTGACAAA AGATGTTGAAAGGATGAAAAAAGGTATAGTAGACATACACTAACCAAAAATGTAGCTCTTTGAATCTCAGAAAAAAGTAGATTTTAATAA >28231_28231_3_FAF1-EIF5_FAF1_chr1_51048290_ENST00000545823_EIF5_chr14_103805509_ENST00000216554_length(amino acids)=312AA_BP=129 MRNLLEMCLAESGLSYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGD ALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEAFYVKARDKKKEEGVIDSSDKEIVAEAERLDVKAMGPLVLTEVLFNEKIREQIKKYRRH FLRFCHNNKKAQRYLLHGLECVVAMHQAQLISKIPHILKEMYDADLLEEEVIISWSEKASKKYVSKELAKEIRVKAEPFIKWLKEAEEES -------------------------------------------------------------- >28231_28231_4_FAF1-EIF5_FAF1_chr1_51048290_ENST00000545823_EIF5_chr14_103805509_ENST00000558506_length(transcript)=3265nt_BP=537nt ATACAAAGCAGGCTTGAGATGTATCCTTGCATATTTGAAGGTTCTGTGGTTATGATGAGCTGAAATGACCACTGATTAATACAGTAGCTC TCTAAAATAATGAGGTTTCTCCACTAACGGAACCTCTTTATTTATCAAACTTATAATAAAATGAGGAATCTGCTTGAGATGTGTCTTGCT GAATCAGGGCTCTCTTATCCCTGCCATCGACTTACAGTGGGAAGAAGATCTTCACCTGCACAGACCCGGGAACAGTCGGAAGAACAAATC ACCGATGTTCATATGGTTAGTGATAGCGATGGAGATGACTTTGAAGATGCTACAGAATTTGGGGTGGATGATGGAGAAGTATTTGGCATG GCGTCATCTGCCTTGAGAAAATCTCCAATGATGCCAGAAAACGCAGAAAATGAAGGAGATGCCTTATTACAATTTACAGCAGAGTTTTCT TCAAGATATGGTGATTGCCATCCTGTATTTTTTATTGGCTCATTAGAAGCTGCTTTTCAAGAGGCCTTCTATGTGAAAGCCCGAGATAAA AAGAAAGAAGAGGGTGTTATTGATTCATCTGACAAAGAAATCGTTGCTGAAGCAGAAAGACTGGATGTAAAAGCCATGGGCCCTCTTGTT CTAACTGAAGTTCTTTTTAATGAGAAGATTAGAGAACAGATTAAGAAATACAGGCGCCATTTCCTACGATTTTGTCACAACAACAAAAAA GCCCAACGGTACCTTCTTCATGGTTTGGAGTGTGTGGTAGCAATGCATCAAGCTCAGCTTATCTCCAAGATTCCACATATCTTGAAGGAG ATGTACGATGCAGACCTTTTAGAAGAAGAGGTCATCATCAGCTGGTCGGAAAAGGCCTCTAAGAAATATGTCTCCAAAGAACTTGCCAAA GAGATTCGTGTCAAAGCAGAACCATTTATAAAATGGTTGAAGGAGGCAGAGGAAGAATCTTCTGGTGGCGAAGAAGAAGATGAAGATGAG AACATTGAGGTGGTGTATTCGAAGGCTGCCAGTGTACCGAAAGTTGAGACTGTAAAGTCAGACAACAAGGATGACGACATCGATATTGAT GCCATTTAAAGGGATGGATGCAACCTAGCTTAACAGTATAATGCTGCAAATTTTCCTCCATTATCAGCCAGAAGTGCAACATGTATGTGC AAAAGCTAAAATGGCTTAACATCATGCTACACTTTACACTAAAAATCTATTACTGTGAGTGGTCTGTTATTAAGCCCAATGAGACATCTA GGGAGTCCATACACATCAGTGAGCAGATGTAGTTTGCTTATTTATAGCATGTTTCTTTTTGAAAAACTAGTGGTGGACACATTTGGATCA CATTTATACAGTTATAAAAATAAAGGTTTGATTTTGGTCGTTCTTCAGATGTTTGGCTCTGAATGACTTAAGCTGAAGTAACTGGCTCCT TACTTTAAATGTTCTGCCATCATTTCACCTGATGAGCATTCTTGGAGCCTGCCAGATATTGTTAGGTCCTGGGGCTGCAAAGAGGTCCTC AACAGGATGTAAAGCAAACTTAATTGTAATTAATTTATTCAGCCCATTAAGAAAGTACTAAAGTTTTATCTCTGTAGTTCCTCAAATTGG CATCTGGTAATGTACATTGTGAGGTAGACTGATAATGAAATGACAGTGTAACATCTTAACCAAGAAGTAAATATGACCTCAGTGTCCTAT AAATAATGTAAGAGCAGGATTTGAAACTTGGAGAGCTGTTTTCTCATTTCATGTACACTTGCCCCAAATTGTCTTTGAAGTCGTGTGCAT TGCACGTTGGATGAGCCAGGGAAATTATTACATTAACAAGCATTTTGTGTGTACGTAGTAGTTACTTTGTACTGAGAGAACTTGCTTTGG GGTGCAATTAATAAACTGATTTTATTTGGGAGAAACAAGGAAGGGTGCACTTAACTAGCAACCTAAGCATGATTTTTCAGCTTTTGCCCT TAGGGTTTAAATTACAATTCCAAAATGTTAGACATACTGTATTTTTTCGTTCAGTGTGGCTTTAATTTTCCCCTCTTGCAGTTTGTTCTG TAATGCCTTTTACATTTGGACACATAGTTTATGCTTTTTAGATTTTGGTTGCTTTCTTGCCAAAATAAGTGTTAACTGTGTTTCAAACTT GATTTTCTTTCCTTTTTCTTTTTTTTTTCTTCCAGAATGTCTTATTTAAAAAGAAAGCTAAAAGCATACTTCTAAGTCAGAGCCTCTATT TTGGTGTAAGACTTGGGATATTTTTTACTTCACATTGAATATAGCCAGGCACCCAAGAAGTCTGATGGCCACCTGAGTGCAGGTGACAAG GACCTGACAGAGCCCATGCAGGGCTTTAGATTTGGACACACAAGAGTTGATAACTTCCTCATGAACTCCTTGCCTGATCTAAACTCATAT TATGGGTTCTGACTGTTTGAGTAATCATCTTCAAGGTTAAACCTCTTGGCAGTTACCCTTTTCACAAAGTGCACAGTGGGAATCGAGAAT CGATAGGGTTAATTTTGGAGCAGTGGCTTATACCATTCACCTCTGTTTTTTTGTGATTATTTCACAGATAATGAGACCTTAATAACAAAT AGGCGTAAAAAAATTTTCACATTGAAATGATAGAAACATTTGATGTAATAAAACTTGGTTGGCTTGATATTTTAAGGAATTGAAACCTAG CAATCTTATTGGAGAGACAAGAATTGGTCTCCAGCTGCCTTTGATCAAGATTCGGGTGCAAGTGGAGCAGGAGCCATATACCTGGAGGGA ATGTGCTTTGTCACACCAAAGAGGATTTTTTTTTCTTCAAACTTGTATGTTGCCTAGGTTTCAAATTCTTTGCCGCAAGGCTGATCTGCT TTCATTAACTGGAATTCTGTAGGAGATACTGGTGACCTAAGCTAAGTTGCACTCAGCATACTCAGTGTCAAGCTAATGAGGTTCTATTAT AAAGGTTCTACTTTTAATCTGAGGGAAAACATGTTCAGGGCTTCTAGAACACTAAAAAATTTGGCTTAAACCAGTGTTCAGTCTGGTGCC AAACTTCGAATGGAATACAAATTCACATAATCTGAACTTTGTTCACAGGTTATCCTAATAGAGTAATTCTTCACTTTGCTCTATTGAACT GTCTTAAGGATTTGTTTAAACAGCTAAGTTACTTGATTAAAATAATGATAAAATTGTATTTTGTCTTTGCTTTAATATTAAAGTTAACAA >28231_28231_4_FAF1-EIF5_FAF1_chr1_51048290_ENST00000545823_EIF5_chr14_103805509_ENST00000558506_length(amino acids)=312AA_BP=129 MRNLLEMCLAESGLSYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGD ALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEAFYVKARDKKKEEGVIDSSDKEIVAEAERLDVKAMGPLVLTEVLFNEKIREQIKKYRRH FLRFCHNNKKAQRYLLHGLECVVAMHQAQLISKIPHILKEMYDADLLEEEVIISWSEKASKKYVSKELAKEIRVKAEPFIKWLKEAEEES -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for FAF1-EIF5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FAF1-EIF5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FAF1-EIF5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |